In summary, as a competing endogenous RNA (ceRNA), CHRF drives the EMT process and promotes the progression of IPF by negatively regulating miR-146a and positively regulating L1CAM (Figure 3). This evidence concerns the gene L1CAM and idiopathic pulmonary fibrosis.